|4Aug 15, 4:47 PM ET

Degnan Chris 4

4 · Verrica Pharmaceuticals Inc. · Filed Aug 15, 2018

Insider Transaction Report

Form 4
Period: 2018-06-19
Degnan Chris
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-06-19$15.00/sh+3,000$45,0003,000 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION